Written by Greg Arnold, DC, CSCS. Of the 70 participating women with gestational diabetes, those who supplemented with selenium for 6 weeks had a significant improvement in blood sugar control, and an 11.5 % increase in glutathione blood levels as well as improved inflammation levels.

Gestational diabetes is one a frequent complications of pregnancy (1) and can be associated with more serious problems such as pre-eclampsia, preterm birth, and a higher frequency of induced C-section deliveries (2, 3). Gestational diabetes increases the risk of getting type 2 diabetes after pregnancy (4, 5) and also has long-term health consequences for offspring, including increasing their risk of becoming overweight or obese (6) and developing type 1 or type 2 diabetes later in life (7).

While research has shown exercise to decrease the risk of gestational diabetes by as much as 36% (p = 0.038), a new study suggests that selenium supplementation to be a benefit to maternal health. In the study, 70 women with gestational diabetes were given either 200 milligrams of selenium (35 women) or placebo (35 women) per day for 6 weeks (from weeks 24 to 28 of pregnancy). Blood samples were taken before and after the supplementation period.

After 6 weeks, the following results were noted in the groups, with significant improvements seen in the ability of those in the selenium group to control their blood sugar as well as achieving healthier levels of inflammation:

SeleniumPlacebop-value
Fasting Blood Sugar
(milligrams/deciliter)
10.7% decrease
(99.45 to 88.90)
5% increase
(89.51 to 94.02)
< 0.001
Insulin
(milliInternational Units)
14.7% decrease
(13.52 to 11.54)
35.8% increase
(14.69 to 19.95)
0.005
HOMA-IR25.7% decrease
(3.27 to 2.43)
44.2% decrease
(3.32 to 4.79)
< 0.001
hs-C Reactive Protein
(nanograms/mL)
15.5% decrease
(5128.18 to 4336.30)
8% increase
(6190 to 6691.18)
0.02

While the benefits to improving blood sugar control lie in helping maintain cardiovascular health by helping maintain healthy blood pressure and thereby reduce future risks of cardiovascular disease, the benefits to healthier levels of inflammation also produce long-term cardiovascular health (10), with the mechanism thought to lie in selenium’s ability to inhibit the function of an inflammatory protein called NF-kB (11).

In addition, those in the selenium group experienced an 11.5% increase in blood levels of glutathione (452.33 to 504.57 micromole/Liter) compared to a 7.3% decrease in the placebo group (552.37 to 512.44, p 0.002). As those with poor blood sugar control have high levels of cell damage (12), selenium offers another facet of health maintenance for gestational diabetics.

In the study, “Selenium supplementation in pregnant women with gestational diabetes demonstrated beneficial effects on glucose metabolism, hs-CRP levels, and biomarkers of oxidative stress.”

Source: Asemi, Zatollah, et al. “Effects of selenium supplementation on glucose homeostasis, inflammation, and oxidative stress in gestational diabetes: Randomized, double-blind, placebo-controlled trial.” Nutrition 31.10 (2015): 1235-1242.

© 2015 Elsevier Inc. All rights reserved

Click here to read the full text study.

Posted November 2, 2015.

Greg Arnold is a Chiropractic Physician practicing in Hauppauge, NY.  You can contact Dr. Arnold directly by emailing him at PitchingDoc@msn.com or visiting his web site at www.PitchingDoc.com.

References:

  1. American Diabetes Association.  Gestational dieabetes mellitus. Diab Care 2004;27 (Suppl 1):S88–90
  2. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New Engl J Med 2005;352:2477–86
  3. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. New Engl J Med 2009;361:1339–48
  4. Wendland EM, Torloni MR, Falavigna M, Trujillo J, Dode MA, Campos M, et al.  Gestational diabetes and pregnancy outcomes-a systematic review of the (WHO) and the (IADPSG) diagnostic criteria. BMC Preg Childbirth 2012;12:23
  5. Chodick G, Elchalal U, Sella T, Heymann AD, Porath A, Kokia E, et al. The risk of overt diabetes mellitus among women with estational diabetes: a population-based study. Diabetes Med 2010;27:779–85
  6. Harder T, Roepke K, Diller N, Stechling Y, Dudenhausen JW, Plagemann A. Birth weight, early weight gain, and subsequent risk of type 1 diabetes: systematic review and meta-analysis. Am J Epidemiol 2009;169:1428–36
  7. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2003;27 (Suppl 2):S99–105
  8. Sanabria-Martı´nez G. Effectiveness of physical activity interventions on preventing gestational diabetes mellitus and excessive maternal weight gain: a meta-analysis . BJOG 2015 Jun 3. doi: 10.1111/1471-0528.13429. [Epub ahead of print]
  9. Asemi Z.  Effects of selenium supplementation on glucose homeostasis, inflammation, and oxidative stress in gestational diabetes: Randomized, double-blind, placebo-controlled trial. Nutrition 2015 Oct;31(10):1235-42. doi: 10.1016/j.nut.2015.04.014. Epub 2015 May 14
  10. Lopez-Tinoco C, Roca M, Fernandez-Deudero A, Garcia-Valero A, Bugatto F, Aguilar-Diosdado M, et al. Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus. Cytokine 2012;58:14–9
  11. He YT, Liu DW, Ding LY, Li Q, Xiao YH. Therapeutic effects and molecular mechanisms of anti-fibrosis herbs and selenium on rats with hepatic fibrosis. World J Gastroenterol 2004;10:703–6
  12. Alissa EM, Bahijri SM, Ferns GA. The controversy surrounding selenium and cardiovascular disease: a review of the evidence. Med Sci Monit 2003;9:RA9–R18.